Park, J.-H.; Park, S.Y.; Jung, E.-J.; Ju, Y.-T.; Jeong, C.-Y.; Kim, J.-Y.; Park, T.; Park, M.; Lee, Y.-J.; Jeong, S.-H.
SMARCD3 Promotes Epithelial–Mesenchymal Transition in Gastric Cancer by Integrating PI3K-AKT and WNT/β-Catenin Pathways. Cancers 2025, 17, 3526.
https://doi.org/10.3390/cancers17213526
AMA Style
Park J-H, Park SY, Jung E-J, Ju Y-T, Jeong C-Y, Kim J-Y, Park T, Park M, Lee Y-J, Jeong S-H.
SMARCD3 Promotes Epithelial–Mesenchymal Transition in Gastric Cancer by Integrating PI3K-AKT and WNT/β-Catenin Pathways. Cancers. 2025; 17(21):3526.
https://doi.org/10.3390/cancers17213526
Chicago/Turabian Style
Park, Ji-Ho, Sun Yi Park, Eun-Jung Jung, Young-Tae Ju, Chi-Young Jeong, Ju-Yeon Kim, Taejin Park, Miyeong Park, Young-Joon Lee, and Sang-Ho Jeong.
2025. "SMARCD3 Promotes Epithelial–Mesenchymal Transition in Gastric Cancer by Integrating PI3K-AKT and WNT/β-Catenin Pathways" Cancers 17, no. 21: 3526.
https://doi.org/10.3390/cancers17213526
APA Style
Park, J.-H., Park, S. Y., Jung, E.-J., Ju, Y.-T., Jeong, C.-Y., Kim, J.-Y., Park, T., Park, M., Lee, Y.-J., & Jeong, S.-H.
(2025). SMARCD3 Promotes Epithelial–Mesenchymal Transition in Gastric Cancer by Integrating PI3K-AKT and WNT/β-Catenin Pathways. Cancers, 17(21), 3526.
https://doi.org/10.3390/cancers17213526
